vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and KINGSTONE COMPANIES, INC. (KINS). Click either name above to swap in a different company.

KINGSTONE COMPANIES, INC. is the larger business by last-quarter revenue ($56.4M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs -4.8%, a 30.9% gap on every dollar of revenue. On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $73.1M). Over the past eight quarters, KINGSTONE COMPANIES, INC.'s revenue compounded faster (25.6% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...

IRWD vs KINS — Head-to-Head

Bigger by revenue
KINS
KINS
1.2× larger
KINS
$56.4M
$47.7M
IRWD
Growing faster (revenue YoY)
KINS
KINS
+81.3% gap
KINS
34.0%
-47.3%
IRWD
Higher net margin
KINS
KINS
30.9% more per $
KINS
26.2%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$1.5M more FCF
IRWD
$74.6M
$73.1M
KINS
Faster 2-yr revenue CAGR
KINS
KINS
Annualised
KINS
25.6%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
KINS
KINS
Revenue
$47.7M
$56.4M
Net Profit
$-2.3M
$14.8M
Gross Margin
Operating Margin
14.3%
32.7%
Net Margin
-4.8%
26.2%
Revenue YoY
-47.3%
34.0%
Net Profit YoY
-200.9%
171.4%
EPS (diluted)
$0.01
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
KINS
KINS
Q4 25
$47.7M
$56.4M
Q3 25
$122.1M
$55.7M
Q2 25
$85.2M
$52.3M
Q1 25
$41.1M
$50.5M
Q4 24
$90.5M
$42.1M
Q3 24
$91.6M
$40.8M
Q2 24
$94.4M
$36.5M
Q1 24
$74.9M
$35.8M
Net Profit
IRWD
IRWD
KINS
KINS
Q4 25
$-2.3M
$14.8M
Q3 25
$40.1M
$10.9M
Q2 25
$23.6M
$11.3M
Q1 25
$-37.4M
$3.9M
Q4 24
$2.3M
$5.4M
Q3 24
$3.6M
$7.0M
Q2 24
$-860.0K
$4.5M
Q1 24
$-4.2M
$1.4M
Operating Margin
IRWD
IRWD
KINS
KINS
Q4 25
14.3%
32.7%
Q3 25
61.8%
24.6%
Q2 25
53.2%
27.1%
Q1 25
-70.7%
9.3%
Q4 24
34.8%
15.9%
Q3 24
28.0%
22.3%
Q2 24
26.5%
15.7%
Q1 24
14.7%
5.0%
Net Margin
IRWD
IRWD
KINS
KINS
Q4 25
-4.8%
26.2%
Q3 25
32.8%
19.5%
Q2 25
27.7%
21.5%
Q1 25
-90.9%
7.7%
Q4 24
2.5%
12.9%
Q3 24
4.0%
17.1%
Q2 24
-0.9%
12.4%
Q1 24
-5.6%
4.0%
EPS (diluted)
IRWD
IRWD
KINS
KINS
Q4 25
$0.01
$1.09
Q3 25
$0.23
$0.74
Q2 25
$0.14
$0.78
Q1 25
$-0.23
$0.27
Q4 24
$0.03
$0.44
Q3 24
$0.02
$0.55
Q2 24
$-0.01
$0.37
Q1 24
$-0.03
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
KINS
KINS
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$4.4M
Stockholders' EquityBook value
$-261.8M
$122.7M
Total Assets
$396.9M
$453.4M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
KINS
KINS
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
IRWD
IRWD
KINS
KINS
Q4 25
$4.4M
Q3 25
$199.5M
$4.8M
Q2 25
$199.3M
$5.1M
Q1 25
$199.2M
$5.4M
Q4 24
$199.0M
$11.2M
Q3 24
$198.8M
$17.3M
Q2 24
$198.6M
$25.3M
Q1 24
$398.3M
$25.3M
Stockholders' Equity
IRWD
IRWD
KINS
KINS
Q4 25
$-261.8M
$122.7M
Q3 25
$-264.2M
$107.7M
Q2 25
$-308.2M
$94.9M
Q1 25
$-334.1M
$82.2M
Q4 24
$-301.3M
$66.7M
Q3 24
$-311.3M
$59.7M
Q2 24
$-321.7M
$40.8M
Q1 24
$-330.5M
$35.7M
Total Assets
IRWD
IRWD
KINS
KINS
Q4 25
$396.9M
$453.4M
Q3 25
$396.1M
$428.6M
Q2 25
$342.9M
$393.4M
Q1 25
$327.2M
$385.4M
Q4 24
$350.9M
$374.9M
Q3 24
$389.5M
$347.0M
Q2 24
$395.6M
$319.8M
Q1 24
$438.8M
$318.3M
Debt / Equity
IRWD
IRWD
KINS
KINS
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.05×
Q1 25
0.07×
Q4 24
0.17×
Q3 24
0.29×
Q2 24
0.62×
Q1 24
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
KINS
KINS
Operating Cash FlowLast quarter
$74.6M
$75.9M
Free Cash FlowOCF − Capex
$74.6M
$73.1M
FCF MarginFCF / Revenue
156.3%
129.5%
Capex IntensityCapex / Revenue
0.0%
5.0%
Cash ConversionOCF / Net Profit
5.14×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$124.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
KINS
KINS
Q4 25
$74.6M
$75.9M
Q3 25
$47.6M
$25.9M
Q2 25
$-15.1M
$9.3M
Q1 25
$20.0M
$17.9M
Q4 24
$15.2M
$57.9M
Q3 24
$9.9M
$21.7M
Q2 24
$33.5M
$7.1M
Q1 24
$45.0M
$6.1M
Free Cash Flow
IRWD
IRWD
KINS
KINS
Q4 25
$74.6M
$73.1M
Q3 25
$47.6M
$25.3M
Q2 25
$-15.1M
$8.7M
Q1 25
$19.9M
$17.0M
Q4 24
$55.6M
Q3 24
$9.9M
$21.0M
Q2 24
$33.4M
$6.6M
Q1 24
$44.9M
$5.6M
FCF Margin
IRWD
IRWD
KINS
KINS
Q4 25
156.3%
129.5%
Q3 25
39.0%
45.4%
Q2 25
-17.7%
16.6%
Q1 25
48.4%
33.7%
Q4 24
132.1%
Q3 24
10.8%
51.6%
Q2 24
35.4%
18.1%
Q1 24
60.0%
15.5%
Capex Intensity
IRWD
IRWD
KINS
KINS
Q4 25
0.0%
5.0%
Q3 25
0.0%
1.2%
Q2 25
0.0%
1.1%
Q1 25
0.1%
1.7%
Q4 24
0.0%
5.6%
Q3 24
0.0%
1.7%
Q2 24
0.1%
1.4%
Q1 24
0.1%
1.5%
Cash Conversion
IRWD
IRWD
KINS
KINS
Q4 25
5.14×
Q3 25
1.19×
2.38×
Q2 25
-0.64×
0.82×
Q1 25
4.60×
Q4 24
6.74×
10.65×
Q3 24
2.71×
3.12×
Q2 24
1.58×
Q1 24
4.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons